Related references
Note: Only part of the references are listed.Functionalized niosomes as a smart delivery device in cancer and fungal infection
Priyadarshi Aparajay et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2022)
Development of potent nanosized isatin-isonicotinohydrazide hybrid for management of Mycobacterium tuberculosis
Wagdy M. Eldehna et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2022)
Formulation and Evaluation of Hybrid Niosomal In Situ Gel for Intravesical Co-Delivery of Curcumin and Gentamicin Sulfate
Viliana Gugleva et al.
PHARMACEUTICS (2022)
Identification of novel furo[2,3-d]pyrimidine based chalcones as potent anti-breast cancer agents: synthesis, in vitro and in vivo biological evaluation
Mai A. Mansour et al.
RSC ADVANCES (2022)
Novel oxindole/benzofuran hybrids as potential dual CDK2/GSK-3β inhibitors targeting breast cancer: design, synthesis, biological evaluation, and in silico studies
Wagdy M. Eldehna et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2021)
Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors
Claudiu T. Supuran
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2021)
Betaxolol-loaded niosomes integrated within pH-sensitive in situ forming gel for management of glaucoma
Ayat Allam et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Intratracheal Administration of Chloroquine-Loaded Niosomes Minimize Systemic Drug Exposure
Hesham A. Saafan et al.
PHARMACEUTICS (2021)
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumors
Shawn C. Chafe et al.
SCIENCE ADVANCES (2021)
Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery
Mahmoud H. Teaima et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2020)
The Antimicrobial Activity of Ciprofloxacin-Loaded Niosomes against Ciprofloxacin-Resistant and Biofilm-Forming Staphylococcus aureus
Mona T. Kashef et al.
INFECTION AND DRUG RESISTANCE (2020)
Development and investigation of timolol maleate niosomal formulations for the treatment of glaucoma
Afaf A. Ramadan et al.
JOURNAL OF PHARMACEUTICAL INVESTIGATION (2020)
Matrix Metalloproteinases: A challenging paradigm of cancer management
Ali Alaseem et al.
SEMINARS IN CANCER BIOLOGY (2019)
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
Xuemei Ge et al.
PHARMACEUTICS (2019)
The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond
Silvia Pastorekova et al.
CANCER AND METASTASIS REVIEWS (2019)
Vancomycin-loaded niosomes integrated within pH-sensitive in-situ forming gel for treatment of ocular infections while minimizing drug irritation
Ayat Allam et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Preparation, physicochemical properties, in vitro evaluation and release behavior of cephalexin-loaded niosomes
Robabehbeygom Ghafelehbashi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Continued exploration and tail approach synthesis of benzenesulfonamides containing triazole and dual triazole moieties as carbonic anhydrase I, II, IV and IX inhibitors
Lalit Vats et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Carbonic anhydrase IX is a critical determinant of pulmonary microvascular endothelial cell pH regulation and angiogenesis during acidosis
Ji Young Lee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2018)
Subcutaneous Ehrlich Ascites Carcinoma mice model for studying cancer-induced cardiomyopathy
Sneha Mishra et al.
SCIENTIFIC REPORTS (2018)
Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors
Yanyan Liu et al.
ACCOUNTS OF CHEMICAL RESEARCH (2018)
Tumor-associated carbonic anhydrase isoform IX and XII inhibitory properties of certain isatin-bearing sulfonamides endowed with in vitro antitumor activity towards colon cancer
Wagdy M. Eldehna et al.
BIOORGANIC CHEMISTRY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Synthesis and In Vitro Anti-Tumor, Anti-Mycobacterial and Anti-HIV Activities of Diethylene-Glycol-Tethered Bis-Isatin Derivatives
Wei Li et al.
CHEMISTRYSELECT (2018)
Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies
Wagdy M. Eldehna et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries
Amal A. Abd-El Fattah et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2017)
Isatin-benzoazine molecular hybrids as potential antiproliferative agents: synthesis and in vitro pharmacological profiling
Hatem A. Abdel-Aziz et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Niosomes: A Strategy toward Prevention of Clinically Significant Drug Incompatibilities
Hebatallah B. Mohamed et al.
SCIENTIFIC REPORTS (2017)
Exosomes expressing carbonic anhydrase 9 promote angiogenesis
Kengo Horie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Design, synthesis and anti-tumor activity study of novel histone deacetylase inhibitors containing isatin-based caps and o-phenylenediamine-based zinc binding groups
Shuai Gao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
Niosomes as Nanoparticular Drug Carriers: Fundamentals and Recent Applications
Didem Ag Seleci et al.
JOURNAL OF NANOMATERIALS (2016)
Inhibition of carbonic anhydrase potentiates bevacizumab treatment in cholangiocarcinoma
Kulthida Vaeteewoottacharn et al.
TUMOR BIOLOGY (2016)
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
Marwa A. Aziz et al.
SCIENTIFIC REPORTS (2016)
Isatin-pyrazole benzenesulfonamide hybrids potently inhibit tumor-associated carbonic anhydrase isoforms IX and XII
Hany S. Ibrahim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design of polymeric nanoparticles for biomedical delivery applications
Mahmoud Elsabahy et al.
CHEMICAL SOCIETY REVIEWS (2012)
Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway
Ming-Ju Hsieh et al.
EUROPEAN JOURNAL OF CELL BIOLOGY (2010)
Selective Inhibition of Carbonic Anhydrase IX Decreases Cell Proliferation and Induces Ceramide-Mediated Apoptosis in Human Cancer Cells
Fabio Cianchi et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
Claudiu T. Supuran
NATURE REVIEWS DRUG DISCOVERY (2008)
Approval summary: Sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma
Vicki L. Goodman et al.
CLINICAL CANCER RESEARCH (2007)
Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro
S Parkkila et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
